Professional Summary

Professional Overview

Lee Babiss is an accomplished pharmaceutical executive with extensive experience leading innovative drug discovery and development initiatives. As the CEO of Gotham Therapeutics, he oversees the strategic direction and operational execution of the company's groundbreaking research programs targeting novel therapeutic targets. Babiss is widely recognized for his expertise in applied genomics, preclinical research, and global pharmaceutical research and development.

Experience Summary

Current Role

As the CEO of Gotham Therapeutics since 2017, Babiss is responsible for spearheading the company's mission to advance the next generation of life-changing therapies. Under his leadership, Gotham Therapeutics has made significant strides in developing innovative small molecule and biologics programs, with several promising drug candidates advancing through the clinical pipeline. Babiss' strategic vision and scientific acumen have been instrumental in positioning Gotham Therapeutics as a leader in the pharmaceutical industry.

Career Progression

Babiss brings a wealth of experience to his current role, having held several high-level positions in the pharmaceutical and biotechnology sectors. Prior to joining Gotham Therapeutics, he served as the CEO of X-Rx, where he led the company's successful transition from a research-focused organization to a clinical-stage biopharmaceutical company. Babiss also held executive roles at PPD, Roche, and GlaxoWelcome Inc., where he made significant contributions to advancing drug discovery and development initiatives.

Throughout his career, Babiss has demonstrated his ability to drive innovation, foster collaborative partnerships, and deliver measurable results. His deep understanding of the pharmaceutical industry, coupled with his strong scientific background, has enabled him to navigate complex challenges and consistently deliver value for stakeholders.

Academic Background

Babiss holds a Ph.D. in Molecular Cell Biology from The Rockefeller University, where he also served as an Adjunct Professor in the Department of Molecular Cell Biology. His academic achievements and research contributions have earned him a reputation as a thought leader in the field of applied genomics and its applications in drug discovery.

Areas of Expertise

• Pharmaceutical research and development

• Applied genomics and translational science

• Preclinical research and development

• Global drug discovery strategy and execution

• Scientific leadership and team management

• Regulatory and commercialization strategy

Professional Impact

Under Babiss' leadership, Gotham Therapeutics has emerged as a leader in the development of innovative therapies, with several promising drug candidates in the clinical pipeline. His ability to identify and capitalize on emerging scientific opportunities, coupled with his strong strategic and operational expertise, has been instrumental in driving the company's success.

Babiss is also an active contributor to the pharmaceutical industry, serving on various advisory boards and participating in industry conferences and publications. His expertise and insights have been instrumental in shaping the direction of drug discovery and development within the broader life sciences ecosystem.

Conclusion

With his extensive experience, deep scientific expertise, and proven track record of success, Lee Babiss is poised to continue leading Gotham Therapeutics to new heights. His unwavering commitment to innovation and his ability to translate scientific breakthroughs into tangible therapeutic solutions make him a valuable asset to the pharmaceutical industry.